170 related articles for article (PubMed ID: 12900528)
1. Analgesic efficacy of etoricoxib in primary dysmenorrhea: results of a randomized, controlled trial.
Malmstrom K; Kotey P; Cichanowitz N; Daniels S; Desjardins PJ
Gynecol Obstet Invest; 2003; 56(2):65-9. PubMed ID: 12900528
[TBL] [Abstract][Full Text] [Related]
2. Analgesic effect of etoricoxib in secondary dysmenorrhea: a randomized, double-blind, crossover, controlled trial.
Ranong CN; Sukcharoen N
J Reprod Med; 2007 Nov; 52(11):1023-9. PubMed ID: 18161400
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, parallel-group study comparing the analgesic effect of etoricoxib to placebo, naproxen sodium, and acetaminophen with codeine using the dental impaction pain model.
Malmstrom K; Kotey P; Coughlin H; Desjardins PJ
Clin J Pain; 2004; 20(3):147-55. PubMed ID: 15100590
[TBL] [Abstract][Full Text] [Related]
4. Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study.
Malmstrom K; Sapre A; Couglin H; Agrawal NG; Mazenko RS; Fricke JR
Clin Ther; 2004 May; 26(5):667-79. PubMed ID: 15220011
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
Daniels S; Robbins J; West CR; Nemeth MA
Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
[TBL] [Abstract][Full Text] [Related]
6. Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled study.
Rasmussen GL; Malmstrom K; Bourne MH; Jove M; Rhondeau SM; Kotey P; Ang J; Aversano M; Reicin AS;
Anesth Analg; 2005 Oct; 101(4):1104-1111. PubMed ID: 16192529
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis.
Peloso PM; Gammaitoni A; Smugar SS; Wang H; Moore AR
BMC Musculoskelet Disord; 2011 Jul; 12():165. PubMed ID: 21767407
[TBL] [Abstract][Full Text] [Related]
8. Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea.
Daniels SE; Talwalker S; Torri S; Snabes MC; Recker DP; Verburg KM
Obstet Gynecol; 2002 Aug; 100(2):350-8. PubMed ID: 12151162
[TBL] [Abstract][Full Text] [Related]
9. A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273].
Collantes E; Curtis SP; Lee KW; Casas N; McCarthy T; Melian A; Zhao PL; Rodgers DB; McCormick CL; Lee M; Lines CR; Gertz BJ;
BMC Fam Pract; 2002 May; 3():10. PubMed ID: 12033987
[TBL] [Abstract][Full Text] [Related]
10. The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain.
Malmstrom K; Ang J; Fricke JR; Shingo S; Reicin A
Curr Med Res Opin; 2005 Jan; 21(1):141-9. PubMed ID: 15881486
[TBL] [Abstract][Full Text] [Related]
11. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
Balazcs E; Sieper J; Bickham K; Mehta A; Frontera N; Stryszak P; Popmihajlov Z; Peloso PM
BMC Musculoskelet Disord; 2016 Oct; 17(1):426. PubMed ID: 27737664
[TBL] [Abstract][Full Text] [Related]
12. Etoricoxib in the treatment of primary dysmenorrhea in Chinese patients: a randomized controlled trial.
Yu Q; Zhu X; Zhang X; Zhang Y; Li X; Hua Q; Chang Q; Zou Q; Di W; Yao Y; Yu W; Liu J; Mehta A; Yan L
Curr Med Res Opin; 2014 Sep; 30(9):1863-70. PubMed ID: 24960147
[TBL] [Abstract][Full Text] [Related]
13. Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen.
Daniels SE; Torri S; Desjardins PJ
J Gen Intern Med; 2005 Jan; 20(1):62-7. PubMed ID: 15693930
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
van der Heijde D; Baraf HS; Ramos-Remus C; Calin A; Weaver AL; Schiff M; James M; Markind JE; Reicin AS; Melian A; Dougados M
Arthritis Rheum; 2005 Apr; 52(4):1205-15. PubMed ID: 15818702
[TBL] [Abstract][Full Text] [Related]
15. Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III study.
Viscusi ER; Frenkl TL; Hartrick CT; Rawal N; Kehlet H; Papanicolaou D; Gammaitoni A; Ko AT; Morgan LM; Mehta A; Curtis SP; Peloso PM
Curr Med Res Opin; 2012 Aug; 28(8):1323-35. PubMed ID: 22738802
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of lumiracoxib 200 mg once daily for treatment of primary dysmenorrhea: results from two randomized controlled trials.
Daniels S; Gitton X; Zhou W; Stricker K; Barton S
J Womens Health (Larchmt); 2008 Apr; 17(3):423-37. PubMed ID: 18373490
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea.
Letzel H; Mégard Y; Lamarca R; Raber A; Fortea J
Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):162-8. PubMed ID: 16675091
[TBL] [Abstract][Full Text] [Related]
18. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
Bickham K; Kivitz AJ; Mehta A; Frontera N; Shah S; Stryszak P; Popmihajlov Z; Peloso PM
BMC Musculoskelet Disord; 2016 Aug; 17():331. PubMed ID: 27502582
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis.
Reginster JY; Malmstrom K; Mehta A; Bergman G; Ko AT; Curtis SP; Reicin AS
Ann Rheum Dis; 2007 Jul; 66(7):945-51. PubMed ID: 17142385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
